1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology

3. Executive Summary
3.1. Global Thyroid Gland Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
3.2. Global Thyroid Gland Disorders Treatment Market: Market Snapshot

4. Market Overview
4.1. Global Thyroid Gland Disorders Treatment Market: Product Overview
4.2. Global Thyroid Gland Disorders Treatment Market: Key Industry Developments

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increasing incidence of thyroid gland disorders
5.2.2. Rise in the number of obese, diabetic, and cardiovascular patients, leading to increased risk of thyroid disorders
5.2.3. Growing number of disease awareness programs in developing regions
5.2.4. Focus on spreading awareness about disorders as well as promotional campaigns
5.2.5. Development of effective combination thyroid disorders drug therapies
5.3. Restraints
5.3.1. Rising customer preference for alternative treatments
5.3.2. Asymptomatic nature of thyroid disorders leading to large pool of undiagnosed patients
5.4. Opportunities
5.4.1. Asymptomatic nature of thyroid disorders leading to large pool of undiagnosed patients
5.4.2. Increase in research and development activities
5.5. Global Thyroid Gland Disorders (Hypothyroidism and Hyperthyroidism) Epidemiology
5.6. Global Thyroid Gland Disorders Treatment Market Revenue Forecast
5.7. Global Thyroid Gland Disorders Treatment Market Outlook

6. Global Thyroid Gland Disorders Treatment Market Analysis, by Disorders
6.1. Introduction
6.2. Key Insights
6.3. Global Thyroid Gland Disorders Treatment Market Analysis, by Disorders
6.3.1. Hypothyroidism
6.3.1.1. Levothyroxine
6.3.1.2. Liothyronine
6.3.2. Hyperthyroidism
6.3.2.1. Imidazole
6.3.2.2. Propacil
6.4. Global Thyroid Gland Disorders Treatment Market Forecast, by Disorders
6.4.1. Hypothyroidism
6.4.1.1. Levothyroxine
6.4.1.2. Liothyronine
6.4.2. Hyperthyroidism
6.4.2.1. Imidazole
6.4.2.2. Propacil
6.5. Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
6.5.1. Hypothyroidism
6.5.2. Hyperthyroidism

7. Global Thyroid Gland Disorders Treatment Market Analysis, by Region
7.1. Global Thyroid Gland Disorders Treatment Market Forecast, by Region, 2015-2025
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Latin America
7.1.5. Middle East & Africa
7.2. Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region
7.3. Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region

8. North America Thyroid Gland Disorders Treatment Market Analysis
8.1. North America Thyroid Gland Disorders Treatment Market Key Findings
8.2. North America Thyroid Gland Disorders Treatment Market Overview
8.3. North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
8.3.1. Hypothyroidism
8.3.1.1. Levothyroxine
8.3.1.2. Liothyronine
8.3.2. Hyperthyroidism
8.3.2.1. Imidazole
8.3.2.2. Propacil
8.4. North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
8.4.1. Hypothyroidism
8.4.2. Hyperthyroidism
8.5. North America Thyroid Gland Disorders Treatment Market Forecast, by Country
8.5.1. U.S.
8.5.2. Canada
8.6. North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
8.6.1. Hypothyroidism
8.6.2. Hyperthyroidism

9. Europe Thyroid Gland Disorders Treatment Market Analysis
9.1. Europe Thyroid Gland Disorders Treatment Market Key Findings
9.2. Europe Thyroid Gland Disorders Treatment Market Overview
9.3. Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
9.3.1. Hypothyroidism
9.3.1.1. Levothyroxine
9.3.1.2. Liothyronine
9.3.2. Hyperthyroidism
9.3.2.1. Imidazole
9.3.2.2. Propacil
9.4. Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
9.4.1. Hypothyroidism
9.4.2. Hyperthyroidism
9.5. Europe Thyroid Gland Disorders Treatment Market Forecast, by Country
9.5.1. Germany
9.5.2. U.K.
9.5.3. France
9.5.4. Italy
9.5.5. Spain
9.5.6. Rest of Europe
9.6. Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
9.6.1. Hypothyroidism
9.6.2. Hyperthyroidism

10. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis
10.1. Asia Pacific Thyroid Gland Disorders Treatment Market Key Findings
10.2. Asia Pacific Thyroid Gland Disorders Treatment Market Overview
10.3. Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
10.3.1. Hypothyroidism
10.3.1.1. Levothyroxine
10.3.1.2. Liothyronine
10.3.2. Hyperthyroidism
10.3.2.1. Imidazole
10.3.2.2. Propacil
10.4. Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
10.4.1. Hypothyroidism
10.4.2. Hyperthyroidism
10.5. Asia Pacific Thyroid Gland Disorders Treatment Market Forecast, by Country
10.5.1. China
10.5.2. India
10.5.3. Japan
10.5.4. Australia & New Zealand
10.5.5. Rest of Asia Pacific
10.6. Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
10.6.1. Hypothyroidism
10.6.2. Hyperthyroidism

11. Latin America Thyroid Gland Disorders Treatment Market Analysis
11.1. Latin America Thyroid Gland Disorders Treatment Market Key Findings
11.2. Latin America Thyroid Gland Disorders Treatment Market Overview
11.3. Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
11.3.1. Hypothyroidism
11.3.1.1. Levothyroxine
11.3.1.2. Liothyronine
11.3.2. Hyperthyroidism
11.3.2.1. Imidazole
11.3.2.2. Propacil
11.4. Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
11.4.1. Hypothyroidism
11.4.2. Hyperthyroidism
11.5. Latin America Thyroid Gland Disorders Treatment Market Forecast, by Country
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
11.6.1. Hypothyroidism
11.6.2. Hyperthyroidism

12. Middle East & Africa Thyroid Gland Disorders Treatment Market Analysis
12.1. Middle East & Africa Thyroid Gland Disorders Treatment Market Key Findings
12.2. Middle East & Africa Thyroid Gland Disorders Treatment Market Overview
12.3. Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
12.3.1. Hypothyroidism
12.3.1.1. Levothyroxine
12.3.1.2. Liothyronine
12.3.2. Hyperthyroidism
12.3.2.1. Imidazole
12.3.2.2. Propacil
12.4. Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
12.4.1. Hypothyroidism
12.4.2. Hyperthyroidism
12.5. Middle East & Africa Thyroid Gland Disorders Treatment Market Forecast, by Country
12.5.1. GCC Countries
12.5.2. South Africa
12.5.3. Israel
12.5.4. Rest of Middle East & Africa
12.6. Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
12.6.1. Hypothyroidism
12.6.2. Hyperthyroidism

13. Competition Landscape
13.1. Global Thyroid Gland Disorders Treatment Market Share Analysis, by Company (2016)
13.2. Company Profiles
13.2.1. Merck KGaA
13.2.1.1. Overview (HQ, Employee Strength, Business Segments)
13.2.1.2. Financials
13.2.1.3. Recent Developments
13.2.1.4. Strategy
13.2.2. Pfizer, Inc.
13.2.2.1. Overview (HQ, Employee Strength, Business Segments)
13.2.2.2. Financials
13.2.2.3. Recent Developments
13.2.2.4. Strategy
13.2.3. Takeda Pharmaceutical Company Limited
13.2.3.1. Overview (HQ, Employee Strength, Business Segments)
13.2.3.2. Financials
13.2.3.3. Recent Developments
13.2.3.4. Strategy
13.2.4. ALLERGAN
13.2.4.1. Overview (HQ, Employee Strength, Business Segments)
13.2.4.2. Financials
13.2.4.3. Recent Developments
13.2.4.4. Strategy
13.2.5. Sanofi S.A.
13.2.5.1. Overview (HQ, Employee Strength, Business Segments)
13.2.5.2. Financials
13.2.5.3. Recent Developments
13.2.5.4. Strategy
13.2.6. AbbVie Inc.
13.2.6.1. Overview (HQ, Employee Strength, Business Segments)
13.2.6.2. Financials
13.2.6.3. Recent Developments
13.2.6.4. Strategy
13.2.7. Lannett Company, Inc.
13.2.7.1. Overview (HQ, Employee Strength, Business Segments)
13.2.7.2. Financials
13.2.7.3. Recent Developments
13.2.7.4. Strategy
13.2.8. Aspen
13.2.8.1. Overview (HQ, Employee Strength, Business Segments)
13.2.8.2. Financials
13.2.8.3. Recent Developments
13.2.8.4. Strategy
13.2.9. Novartis AG
13.2.9.1. Overview (HQ, Employee Strength, Business Segments)
13.2.9.2. Financials
13.2.9.3. Recent Developments
13.2.9.4. Strategy
13.2.10. Mylan N.V.
13.2.10.1. Overview (HQ, Employee Strength, Business Segments)
13.2.10.2. Financials
13.2.10.3. Recent Developments
13.2.10.4. Strategy

List of Tables
TABLE 1 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015-2025
TABLE 2 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class,
TABLE 3 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class,
TABLE 4 Global Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2015-2025
TABLE 5 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015-2025
TABLE 6 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015-2025
TABLE 7 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015-2025
TABLE 8 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2015-2025
TABLE 9 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015-2025
TABLE 10 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015-2025
TABLE 11 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015-2025
TABLE 12 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
TABLE 13 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015-2025
TABLE 14 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015-2025
TABLE 15 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015-2025
TABLE 16 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
TABLE 17 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015-2025
TABLE 18 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015-2025
TABLE 19 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015-2025
TABLE 20 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
TABLE 21 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015-2025
TABLE 22 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015-2025
TABLE 23 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015-2025
TABLE 24 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-202

List of Figures
FIG. 1 Global Thyroid Gland Disorders Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2025
FIG. 2 Global Thyroid Gland Disorders Market Value Share, by Disorders (2016)
FIG. 3 Global Thyroid Gland Disorders Market Value Share, by Hypothyroidism Drug Class (2016)
FIG. 4 Global Thyroid Gland Disorders Market Value Share, by Region (2016)
FIG. 5 Global Thyroid Gland Disorders Market Value Share, by Hyperthyroidism Drug Class (2016)
FIG. 6 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hypothyroidism, 2015-2025
FIG. 7 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hyperthyroidism, 2015-2025
FIG. 8 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Levothyroxine, 2015-2025
FIG. 9 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Liothyronine, 2015-2025
FIG. 10 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Imidazole, 2015-2025
FIG. 11 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Propacil, 2015-2025
FIG. 12 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 13 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 14 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 15 Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 16 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2016 and 2025
FIG. 17 Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region
FIG. 18 North America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015-2025
FIG. 19 North America Market Attractiveness Analysis, by Country
FIG. 20 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders, 2016 and 2025
FIG. 21 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 22 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 23 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2016 and 2025
FIG. 24 North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 25 Europe Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015-2025
FIG. 26 Europe Market Attractiveness Analysis, by Country
FIG. 27 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 28 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 29 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 30 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 31 Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2015-2025
FIG. 32 Asia Pacific Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015-2025
FIG. 33 Asia Pacific Market Attractiveness Analysis, by Country/Sub-region
FIG. 34 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 35 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 36 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 37 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 38 Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
FIG. 39 Latin America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015-2025
FIG. 40 Latin America Market Attractiveness Analysis, by Country/Sub-region
FIG. 41 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 42 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 43 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 44 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 45 Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 46 Middle East & Africa Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015-2025
FIG. 47 Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
FIG. 48 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 49 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 50 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 51 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 52 Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 53 Global Thyroid Gland Disorders Treatment Market Company Share Analysis (2016)
FIG. 54 Merck KGaA Revenue (US$ Bn) & Y-o-Y Growth (%), 2013-2016
FIG. 55 Merck KGaA Breakdown of Net Sales, by Region, 2016
FIG. 56 Breakdown of Net Sales, by Business Segment, 2016
FIG. 57 Merck KGaA R&D Expenses (US$ Bn) & Y-o-Y Growth (%), 2014-2016
FIG. 58 Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 59 Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 60 Pfizer, Inc. Breakdown of Net Sales, by Region, 2016
FIG. 61 Pfizer, Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 62 Takeda Pharmaceutical Company Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 63 Takeda Pharmaceutical Company Limited R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 64 Takeda Pharmaceutical Company Limited Breakdown of Net Sales, by Region
FIG. 65 Takeda Pharmaceutical Company Limited Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 66 ALLERGAN Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 67 ALLERGAN R&D Spending and Sales & Marketing Expenses - Company Level, 2015-2016
FIG. 68 ALLERGAN Breakdown of Net Sales, by Operating Segment, 2016
FIG. 69 Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 70 Sanofi S.A. R&D Spending and Sales & Marketing Expenses - Company Level, 2014-2016
FIG. 71 Sanofi S.A. Breakdown of Net Sales, by Region, 2016
FIG. 72 Sanofi S.A. Breakdown of Net Sales, by Business Segment, 2016
FIG. 73 AbbVie Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 74 AbbVie Inc. R&D Expenses and Sales & Marketing Expenses- Company Level, 2015-2016
FIG. 75 AbbVie Inc. Breakdown of Net Sales, by Region, 2016
FIG. 76 AbbVie Inc. Breakdown of Net Sales, by Major Brands, 2016
FIG. 77 Lannett Company, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
FIG. 78 Lannett Company, Inc. Breakdown of Net Sales, by Business Segments, 2016
FIG. 79 Lannett Company, Inc. Breakdown of Net Sales, by Customer Distribution Channel, 2016
FIG. 80 Aspen Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
FIG. 81 Aspen R&D Expenses and Sales & Marketing Expenses(%) - Company Level, 2015-2016
FIG. 82 Aspen Breakdown of Net Sales, By Region 2016
FIG. 83 Aspen Breakdown of Net Sales, (Overall Company Level), 2016
FIG. 84 Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
FIG. 85 Novartis AG R&D Expenses and Sales & Marketing Expenses(%) - Company Level, 2015-2016
FIG. 86 Novartis AG Breakdown of Net Sales, By Region 2016
FIG. 87 Novartis AG Breakdown of Net Sales, Business Segments, 2016
FIG. 88 Mylan N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013-2016
FIG. 89 Mylan N.V. R&D Expenses and Sales & Marketing Expenses(%) - Company Level, 2015-2016
FIG. 90 Mylan N.V. Breakdown of Net Sales, By Region 2016
FIG. 91 Mylan N.V. Breakdown of Net Sales, Business Segments, 2016